early infancy

Gut microbes influence cognitive performance in baby mice

The findings of a recent study show that specific gut microbes and their metabolites affect cognition and memory when transplanted into germ-free mice.

Study characterizes the microbiota of milk from mothers with preterm infants

The findings of a recent study shed light on the microbiota of the main nutrition types that preterm infants receive and may inform future studies on the influence of different…

Mice study hints at how gut microbes may protect from childhood obesity

The findings of a recent study suggest that the microbiota-derived metabolite phenyllactic acid can prevent antibiotic-associated obesity in early life.

Linking gut microbiota diversity to survival outcomes in children’s stem cell transplants

Results from a recent study suggest a correlation between the diversity and composition of the gut microbiota prior to transplantation and both the patient's survival and the probability of developing…

Socio-economic adversities are associated with gut microbiota alterations

Microbial differences may help to identify targets that could be modulated to mitigate health inequities.

Nestlé’s innovation: elevating infant nutrition with HMOs and probiotic synergy for science-based early-life health

Nestlé, a global leader in nutrition and wellness, is taking a giant leap forward in early-life nutrition with its latest innovation – Sinergity.

Can vaginal microbiota transfer influence a newborn’s health?

Larger studies with longer follow-ups are needed to assess whether and how VMT influences neurodevelopment.

Study identifies factors that influence the infant gut microbiota

Analyzing how different exposures affect the infant gut microbiota could help researchers identify confounding factors and potential microbiota modulators.

Vaginal seeding may benefit babies born by C-section, small clinical study shows

The findings of a recent study suggest that vaginal seeding is safe and may normalize the gut microbiota in infants born by C-section.

Additional Infant Bacterial Therapeutics product receives FDA orphan drug designation

The FDA has granted orphan drug designation for IBT’s product IBP-1016 for gastroschisis.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top